5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) POLYMORPHISM AND PANCREATIC CANCER: RESULTS FROM THE RTOG 9704 PROSPECTIVE RANDOMIZED ADJUVANT TREATMENT TRIAL
James J. Farrell(Yale New Haven Hospital), Hany Elsaleh(Sir Charles Gairdner Hospital), Ross A. Abrams(Rush University Medical Center), Marius van Rijnsoever, Majid Mohiuddin(Moog (United States)), William F. Regine(University of Kentucky), K. Winter(Moog (United States)), John Hoffman(Moog (United States)), Paul Schaeffer(Universidad La Salle), Christopher Willett(Moog (United States)), J. S. Macdonald(SWOG Cancer Research Network), A.B. Benson(Moog (United States)), H. Safran(Moog (United States))
Cited by 0
Related Papers
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|943
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases
|International Journal of Radiation Oncology*Biology*Physics|2002|508
PGC-1α Coactivates PDK4 Gene Expression via the Orphan Nuclear Receptor ERRα: a Mechanism for Transcriptional Control of Muscle Glucose Metabolism
|Molecular and Cellular Biology|2005|355